Sort   by:  
 Page size 
UnknownSafer Solvents for Active Pharmaceutical Ingredient Purification Using Column Chromatography.
Not available
S-EPMC11413887 | biostudies-literature
UnknownA Retrospective Observational Study to Determine Baseline Characteristics and Early Prescribing Patterns for Patients Receiving Alirocumab in UK Clinical Practice.
Not available
S-EPMC6879683 | biostudies-literature
UnknownSignificant Reduction of Late Toxicities in Patients With Extremity Sarcoma Treated With Image-Guided Radiation Therapy to a Reduced Target Volume: Results of Radiation Therapy Oncology Group RTOG-0630 Trial.
Not available
S-EPMC4486342 | biostudies-literature
UnknownSWOG S0221: a phase III trial comparing chemotherapy schedules in high-risk early-stage breast cancer.
Not available
S-EPMC4268253 | biostudies-literature
UnknownMolecular insights into antibody-mediated protection against the prototypic simian immunodeficiency virus.
Not available
S-EPMC9446601 | biostudies-literature
UnknownThe First Mitochondrial Genomics and Evolution SMBE-Satellite Meeting: A New Scientific Symbiosis.
Not available
S-EPMC5714122 | biostudies-literature
UnknownTelemedicine visits in myasthenia gravis: Expert guidance and the Myasthenia Gravis Core Exam (MG-CE).
Not available
S-EPMC9057373 | biostudies-literature
UnknownEngineering SARS-CoV-2 neutralizing antibodies for increased potency and reduced viral escape pathways.
Not available
S-EPMC9367177 | biostudies-literature
UnknownCalorie intake and patient outcomes in severe acute kidney injury: findings from The Randomized Evaluation of Normal vs. Augmented Level of Replacement Therapy (RENAL) study trial.
Not available
S-EPMC4057152 | biostudies-literature
UnknownRapid isolation of potent SARS-CoV-2 neutralizing antibodies and protection in a small animal model.
Not available
S-EPMC7263516 | biostudies-literature
Sort   by:  
 Page size